14 Paid Clinical Research Studies in Mobile, Alabama

Filtered for protocols that accept healthy volunteers or mention compensation. Always confirm stipend details and screening with the study coordinator.

Phase2

A Trial of Vigil for Participants With Ovarian Cancer

The goal of this clinical trial is to compare participants with ovarian, fallopian tube or primary peritoneal cancer when treated with investigational product (Vigil) compared to p

📍 University of South Alabama Mitchell Cancer Institute — Mobile, Alabama

💵 Participants will receive Vigil or placebo by intradermal injection once a month for at least 4 and up to a maximum of 6

View Study & Checklist ➔
Phase2

Abemaciclib and Letrozole to Treat Endometrial Cancer

This is a phase II single arm trial to determine the percentage of patients without evidence of disease progression on abemaciclib and letrozole in advanced stage, persistent or re

📍 University of South Alabama Mitchell Cancer Center — Mobile, Alabama

💵 Patients must have adequate organ and marrow function as defined below NOTE: Institutional/laboratory upper limit of nor

View Study & Checklist ➔
Phase2

A Study to Evaluate Adverse Events of Subcutaneous (SC) Epcoritamab Administered in the Outpatient Setting in Adult Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma and Classic Follicular Lymphoma

B-cell Lymphoma is an aggressive and rare cancer of a type of immune cells (a white blood cell responsible for fighting infections). Classic Follicular Lymphoma is a slow-growing t

📍 Infirmary Health - Infirmary Cancer Care at Mobile Infirmary /ID# 264630 — Mobile, Alabama

💵 Participants will receive escalating doses of epcoritamab, until full dose is achieved.

View Study & Checklist ➔
Interventional Protocol

Caris Biorepository Research Protocol

The Biorepository for Caris Life Sciences is designed for the purpose of making quality biospecimens and associated clinical data available for research studies related to advancin

📍 University of South Alabama — Mobile, Alabama

View Study & Checklist ➔
Phase3

A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures

This is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study to evaluate the clinical efficacy, safety, and tolerability of XEN1101 administered as adjunctive

📍 University of Alabama - Strada Patient Care Center, Neurology — Mobile, Alabama

💵 Eligible subjects will have up to 9.5 weeks durations to assess the baseline frequency of seizures, followed by a double

View Study & Checklist ➔